Systematic Literature Review Living SLR Meta-Analysis Evidence Grading Medical Affairs KOL Intelligence Congress Intelligence Medical & Scientific Writing HEOR Market Access Investor & BD Reports Evidence Marketplace Clinical Development Competitive Intelligence Always-on Monitors
Pricing Platform Skills Contact
Sign in Request a Demo
Layer 3 — Oncology Data Marketplace

Curated oncology data.
Ready for licensing.

Browse de-identified, IRB-approved oncology datasets from leading academic medical centers, biobanks, and CROs. Request an introduction in minutes.

Browse Datasets List Your Data →
— Datasets available
15+ Tumor types covered
100% De-identified to IRB standard
<48 hr Introduction facilitated
Filter
Dataset Catalogue
Loading…
🧬
Datasets launching soon

The Evidara Oncology Data Marketplace is onboarding its first curated suppliers. Datasets will appear here as they are reviewed and approved.

🫁
Solid Tumors — EHR
De-identified longitudinal clinical records with treatment and outcomes
🧬
Genomics Cohorts
WGS/WES with matched clinical annotations and biomarker profiles
🔬
Pathology Imaging
H&E and IHC whole-slide images with structured pathology reports
📊
Real-World Outcomes
Survival, recurrence, and treatment response in real-world populations
🧪
Biomarker Panels
Multi-analyte plasma and tissue biomarker datasets with clinical context
🌍
Global RWE Cohorts
Multi-site, multi-geography datasets for population-level analyses
List your dataset →
For Data Suppliers

Have oncology data
to share?

List your de-identified dataset in the Evidara Marketplace and connect with qualified pharmaceutical buyers — without disclosing supplier identity until you approve each introduction.

Apply as Supplier → Talk to us first
✓
Identity protected until you agree
Buyers see your dataset attributes — not who you are. You approve every introduction before contact details are exchanged.
✓
Full governance review included
Evidara reviews IRB documentation and de-identification approach before any dataset goes live in the catalogue.
✓
Qualified buyers only
Every buyer is screened for legitimate pharmaceutical or biotech use cases before access to supplier details is facilitated.
✓
Audit trail maintained
Every introduction request is logged with buyer identity, stated use case, and timestamp — available to you on request.